Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:NUMIF)

0.0332 -0.0064 (-16.16%)
Streaming Delayed Price Updated: 3:24 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NUMIF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On? ↗
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday. 
Via Benzinga
News headline image
Psychedelics Company Numinus Wellness Reports Q1 2023 Earnings, Initiatives For Wider Access ↗
Mental healthcare psychedelics company Numinus Wellness (OTCQX: NUMIF) shared its financial results for the three months ended November 30, 2022. 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023 ↗
 
Via Benzinga
News headline image
Numinus Wellness Inc. Reports Q1 2023 Results
Q1 2023 revenues grew 618% year-over-year to $5.7 million Q1 2023 gross margin grew to 41.9% from 31.5% in prior quarter Gross profit of $2.4 million, an increase of $1.1 million from prior quarter... 
Via PressReach
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023 ↗
 
Via Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023 ↗
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 9, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023 ↗
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 3, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 9, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022 ↗
 
Via Benzinga
News headline image
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month ↗
Today's article highlights the performance of the munKNEE Psychedelic Drug Stocks Index which tracks the six (6) largest psychedelic stocks researching the treatment of mental illnesses based on the... 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More ↗
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers 
Via Benzinga
News headline image
KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Psychedelic Stock Gainers And Losers From December 12, 2022 ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD ↗
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. 
Via Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research
New clinical trial will provide experiential training to therapists learning to conduct psilocybin-assisted therapy. Clinical trial dosing will use Numinus Bioscience’s Psilocybin Tea, EnfiniTea – one... 
Via PressReach
News headline image
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project ↗
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD ↗
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.